Ichiro Yonese

7PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 06, 2026
Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants.

|May 12, 2026
Adverse impact of bladder biopsy on the rate of intravesical recurrences following radical nephroureterectomy for upper tract urothelial carcinoma.

|Mar 16, 2026
Lymph node metastasis as a favorable prognostic factor in metastatic urothelial carcinoma with histological variants treated with pembrolizumab: a retrospective multicentric study (YUSHIMA study-04).

Ichiro Yonese, Fumitaka Koga, Masahiro Toide

|Mar 12, 2026
Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.

Yosuke Yasuda, Soichiro Yoshida, Sadakatsu Ikeda

|Jan 28, 2026
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis.

Shugo Yajima, Soichiro Yoshida, Wei Chen

|Jan 04, 2024
A case of neoadjuvant chemotherapy-resistant muscle-invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomy.

Ichiro Yonese, Noboru Numao, Kentaro Inamura

Pageof 2

Frequent Collaborators

2 joint publications

Yuji Miura

1 joint publications

Ryo Fujiwara

1 joint publications

Shinya Yamamoto

1 joint publications

Takeshi Yuasa